利用机器学习从临床MALDI-TOF质谱直接预测抗菌药物耐药性
研究开发了从临床分离株的MALDI-TOF质谱图谱直接预测抗菌药物耐药性的机器学习方法,在包含超过30万张质谱和超过75万条耐药表型的数据集上训练分类器。对金黄色葡萄球菌、大肠埃希菌和肺炎克雷伯菌的验证AUC分别为0.80、0.74和0.74。一项63例患者的回顾性临床病例研究显示,实施该方法会改变9例的治疗,其中8例(89%)有益。
要点
- 从MALDI-TOF质谱直接预测耐药性的机器学习方法在三种重点病原体上AUC为0.80、0.74和0.74。
- 回顾性临床病例研究63例中,实施该方法会改变9例治疗,其中8例(89%)有益。
- 基于MALDI-TOF质谱的机器学习可能成为治疗优化和抗生素管理的重要新工具。
核心结论
- 基于MALDI-TOF质谱的机器学习可能成为治疗优化和抗生素管理的重要新工具。
研究设计与样本
- 在来自四家医疗机构的超过30万张质谱与超过75万条抗菌药物耐药表型组成的新建公开数据库上训练校准分类器。
- 对包括金黄色葡萄球菌、大肠埃希菌和肺炎克雷伯菌在内的临床重要病原体 panel 进行验证。
- 进行一项63例患者的回顾性临床病例研究。
主要发现
- 验证得到受试者工作特征曲线下面积分别为金黄色葡萄球菌0.80、大肠埃希菌0.74、肺炎克雷伯菌0.74。
- 回顾性临床病例研究63例中发现,实施该方法会改变9例的临床治疗,其中8例(89%)有益。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Early use of effective antimicrobial treatments is critical for the outcome of infections and the prevention of treatment resistance. Antimicrobial resistance testing enables the selection of optimal antibiotic treatments, but current culture-based techniques can take up to 72 hours to generate results. We have developed a novel machine learning approach to predict antimicrobial resistance directly from matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectra profiles of clinical isolates. We trained calibrated classifiers on a newly created publicly available database of mass spectra profiles from the clinically most relevant isolates with linked antimicrobial susceptibility phenotypes. This dataset combines more than 300,000 mass spectra with more than 750,000 antimicrobial resistance phenotypes from four medical institutions. Validation on a panel of clinically important pathogens, including Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae, resulting in areas under the receiver operating characteristic curve of 0.80, 0.74 and 0.74, respectively, demonstrated the potential of using machine learning to substantially accelerate antimicrobial resistance determination and change of clinical management. Furthermore, a retrospective clinical case study of 63 patients found that implementing this approach would have changed the clinical treatment in nine cases, which would have been beneficial in eight cases (89%). MALDI-TOF mass spectra-based machine learning may thus be an important new tool for treatment optimization and antibiotic stewardship.
引用
- Weis C, Cuénod A, Rieck B, et al. Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning. Nat Med. 2022. PMID: 35013613. doi:10.1038/s41591-021-01619-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。